Biocon gets JDRF support for global study on diabetes molecule Ruby Khatun Khatun7 Sept 2017 10:02 AM ISTNew Delhi: Biotechnology major Biocon on Thursday said it has received financial support from the US-based JDRF for a global clinical study of its...
US judge invalidates Mallinckrodt patents on respiratory treatment Ruby Khatun Khatun7 Sept 2017 9:47 AM ISTA federal judge in Delaware on Tuesday invalidated patents held by Mallinckrodt Pharmaceuticals on its Inomax respiratory treatment system.The ruling...
Once Again: Health Ministry invites suggestions on issue of replacing gelatin capsules Ruby Khatun Khatun6 Sept 2017 5:33 PM ISTNew Delhi: Through a recent notice, Ministry of Health and Family Welfare has once again invited suggestions and comments from the stakeholders...
Ajanta Pharma gets USFDA nod for Parkinsons disease tablet Ruby Khatun Khatun6 Sept 2017 11:08 AM ISTNew Delhi: Ajanta Pharma has received final approval from the US health regulator for Entacapone tablets, used in the treatment of Parkinson's...
Roche lung cancer drug Alecensa slashes brain risk in tests Ruby Khatun Khatun6 Sept 2017 10:17 AM ISTPatients taking Roche’s targeted lung cancer drug Alecensa have a far lower risk of their disease spreading in the brain than those on Pfizer’s...
German Merck considers sale of consumer health business Ruby Khatun Khatun6 Sept 2017 9:42 AM ISTFRANKFURT/COLOGNE: Germany's Merck KGaA is considering selling its $1 billion consumer health unit to meet its financial targets as a decline in its...
Indian-origin Dr Vasant Narasimhan to head Novartis, 48 billion dollar pharma giant Ruby Khatun Khatun5 Sept 2017 1:56 PM ISTZURICH: Novartis Chief Executive Joseph Jimenez will retire in 2018, with chief drug developer Vasant Narasimhan taking over as CEO starting in...
Sayre Therapeutics raises 8 million dollar from Accel, Aarin Capital Ruby Khatun Khatun5 Sept 2017 11:34 AM ISTMumbai: Sayre Therapeutics, a super- specialty pharma company, on Monday said it has raised USD 8 million across two rounds of funding from Accel...
Lupin launches generic hypertension drug in US market Ruby Khatun Khatun5 Sept 2017 10:37 AM ISTNew Delhi: Drug maker Lupin on Monday announced the launch of its Olmesartan Medoxomil tablets, a hypertension drug, in the US market.The company has...
Pfizer gets FDA approval for Mylotarg to treat acute myeloid leukemia Ruby Khatun Khatun5 Sept 2017 10:21 AM ISTThe U.S. Food and Drug Administration (FDA) approved Mylotarg (gemtuzumab ozogamicin) for the treatment of adults with newly diagnosed acute myeloid...
Teva gets FDA approval for AUSTEDO tablets to treat Tardive Dyskinesia in adults Ruby Khatun Khatun5 Sept 2017 10:16 AM ISTJERUSALEM: Teva Pharmaceutical Industries Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved AUSTEDO®(deutetrabenazine)...
Ozone Group partners Brazils Embelleze for hair care products Ruby Khatun Khatun5 Sept 2017 9:21 AM ISTNew Delhi: Pharma and FMCG firm Ozone Group announced its foray into the professional hair care segment by partnering Brazil's Embelleze.Ozone Organic...
